Research graph
References from Beyond Antibiotics: Bacteriophage Therapy Against Multidrug-Resistant Pathogens in the Era of Antimicrobial Resistance. Local targets link to admitted publications; unresolved targets remain external evidence.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
10.1016/s0140-6736(21)02724-0 · 2022 · External reference
Multidrug-resistant Gram-negative bacterial infections
10.1016/s0140-6736(24)02081-6 · 2025 · External reference
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses
10.1016/j.lanmic.2024.100992 · 2025 · External reference
Phage as a prospective arsenal against superbugs
10.1007/s11033-026-12537-9 · 2026 · External reference
A comprehensive review on phage therapy and phage-based drug development
10.3390/antibiotics13090870 · 2024 · External reference
Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies
10.1128/mmbr.00012-19 · 2019 · External reference
The biofilm matrix
10.1038/nrmicro2415 · 2010 · External reference
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process
10.1007/s00253-017-8224-6 · 2017 · External reference
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
10.1038/srep26717 · 2016 · External reference
The current landscape of phage-antibiotic synergistic (PAS) interactions
10.3390/antibiotics14060545 · 2025 · External reference
Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection
10.1128/aac.00954-17 · 2017 · External reference
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
10.1038/s41591-019-0437-z · 2019 · External reference
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
10.1016/s1473-3099(18)30482-1 · 2019 · External reference
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
10.1038/s41564-019-0634-z · 2020 · External reference
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial
10.1016/s1473-3099(20)30330-3 · 2021 · External reference
Regulation of phage therapy medicinal products: developments, challenges, and opportunities
10.3389/fcimb.2025.1631359 · 2025 · External reference
Bacteriophage production in compliance with regulatory requirements
10.1007/978-1-0716-3523-0_6 · 2024 · External reference
Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections
10.3389/fphar.2025.1713471 · 2025 · External reference
Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee
10.1016/j.cmi.2026.06.005 · 2026 · External reference
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections
10.1128/cmr.00044-24 · 2024 · External reference
Clinical application of customized and non-customized bacteriophage therapy in patients with refractory/resistant bacterial infections: A systematic review and meta-analysis
10.1016/j.ijantimicag.2025.107570 · 2025 · External reference
An overview of the current state of phage therapy for the treatment of biofilm-related infections
10.1016/j.coviro.2022.101209 · 2022 · External reference
Giving antibiotics a second chance: evolutionary trade-offs and phage-driven restoration of antibiotic susceptibility
10.1007/s40259-026-00789-7 · 2026 · External reference
Towards accurate artificial intelligence models for strain-level phage-host prediction
10.1093/bib/bbag085 · 2026 · External reference
Bacteriophage production in compliance with regulatory requirements
10.1007/978-1-0716-3523-0_6 · ExternalCitation · doi-reference
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process
10.1007/s00253-017-8224-6 · ExternalCitation · doi-reference
Phage as a prospective arsenal against superbugs
10.1007/s11033-026-12537-9 · ExternalCitation · doi-reference
Giving antibiotics a second chance: evolutionary trade-offs and phage-driven restoration of antibiotic susceptibility
10.1007/s40259-026-00789-7 · ExternalCitation · doi-reference
Towards a reference methodology for bacteriophage susceptibility testing - position paper of the EUCAST Phage Susceptibility Testing Subcommittee
10.1016/j.cmi.2026.06.005 · ExternalCitation · doi-reference
An overview of the current state of phage therapy for the treatment of biofilm-related infections
10.1016/j.coviro.2022.101209 · ExternalCitation · doi-reference
Clinical application of customized and non-customized bacteriophage therapy in patients with refractory/resistant bacterial infections: A systematic review and meta-analysis
10.1016/j.ijantimicag.2025.107570 · ExternalCitation · doi-reference
Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses
10.1016/j.lanmic.2024.100992 · ExternalCitation · doi-reference
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
10.1016/s0140-6736(21)02724-0 · ExternalCitation · doi-reference
Multidrug-resistant Gram-negative bacterial infections
10.1016/s0140-6736(24)02081-6 · ExternalCitation · doi-reference
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
10.1016/s1473-3099(18)30482-1 · ExternalCitation · doi-reference
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial
10.1016/s1473-3099(20)30330-3 · ExternalCitation · doi-reference
The biofilm matrix
10.1038/nrmicro2415 · ExternalCitation · doi-reference
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
10.1038/s41564-019-0634-z · ExternalCitation · doi-reference
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
10.1038/s41591-019-0437-z · ExternalCitation · doi-reference
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
10.1038/srep26717 · ExternalCitation · doi-reference
Towards accurate artificial intelligence models for strain-level phage-host prediction
10.1093/bib/bbag085 · ExternalCitation · doi-reference
Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection
10.1128/aac.00954-17 · ExternalCitation · doi-reference
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections
10.1128/cmr.00044-24 · ExternalCitation · doi-reference
Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies
10.1128/mmbr.00012-19 · ExternalCitation · doi-reference
Regulation of phage therapy medicinal products: developments, challenges, and opportunities
10.3389/fcimb.2025.1631359 · ExternalCitation · doi-reference
Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections
10.3389/fphar.2025.1713471 · ExternalCitation · doi-reference
A comprehensive review on phage therapy and phage-based drug development
10.3390/antibiotics13090870 · ExternalCitation · doi-reference
The current landscape of phage-antibiotic synergistic (PAS) interactions
10.3390/antibiotics14060545 · ExternalCitation · doi-reference
